(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
ByHeart sued over recalled formula by parents of infants sickened with botulism - 25 Breakout Stars in Ongoing television Series
- 3Flu illness count nears 5 million, with New York City among the hardest hit
- 4First Houthi launch toward Israel since war began triggers alerts across the Negev
- 5Vote In favor of Your Favored Kind Of Cheddar
- Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
- Rick Steves Prefers Paying A Bit Extra For This Delectable Food When Dining In Spain
- Kids who get 2-month vaccines on time 7 times more likely to receive MMR shot: Study
- NATO official says members often aren't buying weapons together, and it's a mistake
- Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap
- New study measures titanium in Apollo rock to uncover Moon’s early chemistry
- Ice Spice's 'Big Guy' SpongeBob song is stuck in everyone's heads again — and TikTok is fueling it
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Outer space conditions hamper sperm's ability to navigate toward an egg
